OM:OSSD

Stock Analysis Report

Executive Summary

OssDsign AB (publ), a medtech company, designs, manufactures, and markets implants for healing and treatment of bone defects in Sweden and internationally.

Snowflake

Fundamentals

Excellent balance sheet and overvalued.

Share Price & News

How has OssDsign's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-8.0%

OSSD

5.5%

SE Medical Equipment

2.1%

SE Market


1 Year Return

n/a

OSSD

33.8%

SE Medical Equipment

12.1%

SE Market

Return vs Industry: Insufficient data to determine how OSSD performed against the Swedish Medical Equipment industry.

Return vs Market: Insufficient data to determine how OSSD performed against the Swedish Market.


Shareholder returns

OSSDIndustryMarket
7 Day-8.0%5.5%2.1%
30 Day-26.5%2.4%1.9%
90 Day-21.1%2.6%3.8%
1 Yearn/a35.3%33.8%16.8%12.1%
3 Yearn/a54.7%36.5%32.3%12.4%
5 Yearn/a73.0%44.6%63.0%28.4%

Price Volatility Vs. Market

How volatile is OssDsign's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is OssDsign undervalued compared to its fair value and its price relative to the market?

1.67x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate OSSD's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate OSSD's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: OSSD is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: OSSD is unprofitable, so we can't compare its PE Ratio to the Swedish market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate OSSD's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: OSSD is good value based on its PB Ratio (1.7x) compared to the SE Medical Equipment industry average (4.4x).


Next Steps

Future Growth

How is OssDsign forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

24.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as OssDsign has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has OssDsign performed over the past 5 years?

-10.7%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if OSSD's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare OSSD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OSSD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.3%).


Return on Equity

High ROE: OSSD has a negative Return on Equity (-36.23%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: OSSD is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: OSSD is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is OssDsign's financial position?


Financial Position Analysis

Short Term Liabilities: OSSD's short term assets (SEK167.9M) exceeds its short term liabilities (SEK13.6M)

Long Term Liabilities: OSSD's short term assets (167.9M) exceeds its long term liabilities (3.9M)


Debt to Equity History and Analysis

Debt Level: OSSD's debt to equity ratio (1.7%) is considered satisfactory

Reducing Debt: Insufficient data to determine if OSSD's debt to equity ratio has reduced over the past 5 years.


Balance Sheet

Inventory Level: OSSD has a low level of unsold assets or inventory.

Debt Coverage by Assets: OSSD's debt is covered by short term assets (assets are 53.286250x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: OSSD has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: OSSD has sufficient cash runway for 2.643942 years if free cash flow continues to reduce at historical rates of -30.7% each year.


Next Steps

Dividend

What is OssDsign's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.8%markettop25%4.7%industryaverage1.1%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate OSSD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate OSSD's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if OSSD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OSSD's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of OSSD's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

What is the CEO of OssDsign's salary, the management and board of directors tenure and is there insider trading?

4.8yrs

Average management tenure


CEO

Anders Lundqvist (63yo)

4.8yrs

Tenure

0

Mr. Anders Lundqvist has been Chief Executive Officer and Managing Director at OssDsign AB. since 2015. Mr. Lundqvist served as Chief Executive Officer of SciBase AB (now known as SciBase Holding AB) since ...


Management Age and Tenure

4.8yrs

Average Tenure

52yo

Average Age

Experienced Management: OSSD's management team is considered experienced (4.8 years average tenure).


Board Age and Tenure

3.5yrs

Average Tenure

55yo

Average Age

Experienced Board: OSSD's board of directors are considered experienced (3.5 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Anders Lundqvist (63yo)

    CEO & MD

    • Tenure: 4.8yrs
  • Håkan Engqvist (47yo)

    Co-founder & Director

    • Tenure: 3.8yrs
  • Claes Lindblad (52yo)

    Chief Financial Officer

    • Tenure: 3.5yrs
  • Henrik Hjort

    Director of Marketing & Business Development

    • Tenure: 4.8yrs

Board Members

  • Viktor Drvota (54yo)

    Director

    • Tenure: 3.8yrs
  • Newton Aguiar (55yo)

    Director

    • Tenure: 0.8yrs
  • Anders Qvarnström (59yo)

    Director

    • Tenure: 0.8yrs
  • Simon Cartnell (59yo)

    Chairman of the Board

    • Tenure: 3.5yrs
  • Håkan Engqvist (47yo)

    Co-founder & Director

    • Tenure: 3.8yrs

Company Information

OssDsign AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: OssDsign AB (publ)
  • Ticker: OSSD
  • Exchange: OM
  • Founded: 2011
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: kr305.010m
  • Shares outstanding: 17.73m
  • Website: https://www.ossdsign.com

Number of Employees


Location

  • OssDsign AB (publ)
  • Virdings Allé 2
  • Uppsala
  • Uppsala County
  • 754 50
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
OSSDOM (OMX Nordic Exchange Stockholm)YesOrdinary SharesSESEKMay 2019

Biography

OssDsign AB (publ), a medtech company, designs, manufactures, and markets implants for healing and treatment of bone defects in Sweden and internationally. Its products include OSSDSIGN Cranial, an implant ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/18 22:17
End of Day Share Price2019/10/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.